Company: STAA
Filing Date: 2025-11-04
Form Type: DFAN14A
Source: 0001213900-25-106212
Chunk: 3

Company: STAAR SURGICAL CO
Filing Date: 2025-11-04
Form: DFAN14A
Chunk 3
---
ourned, and then further postponed, the Special Meeting. After this deal is rightly rejected,
the Board will have complete freedom to decide when and how, if at all, to conduct a sale process; the Board therefore does not need Alcon’s
permission to run a ‘go-shop’ and should not further delay the vote.

Lacking facts on their side and good
arguments on the merits, Alcon and STAAR have taken instead to ad hominem attacks. Needless to say, Alcon and STAAR have
grossly misrepresented our track record in specific investments and overall, while ignoring our numerous successes: $1 million invested
with Broadwood at the beginning of 2000 is now worth more than $47 million. If Alcon had generated annualized shareholder returns since
its spinout in 2019 on par with our record, then Alcon’s stock would be trading at more than $150 per share, instead of $75. Perhaps
then Alcon would have the mandate from its own shareholders to pay a fair price for STAAR.

We continue to caution the STAAR Board
against taking any substantive or procedural steps with respect to this transaction without the input and alignment of STAAR’s shareholders.”

Shareholders can learn more at www.LetSTAARShine.com.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood
Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal C. Bradsher is the President of Broadwood Capital.

Broadwood Partners, L.P., Broadwood Capital, Inc.,
Neal C. Bradsher, Richard T. LeBuhn, Natalie R. Capasso, Raymond A. Myers and Jason J. Martin (collectively, the “Participants”)
are participants in the solicitation of proxies from the shareholders of STAAR in connection with the special meeting of shareholders
scheduled for October 23, 2025 (including any adjournments, postponements, reschedulings or continuations thereof, the “Special
Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”)
and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies from the Company’s
shareholders for the Special Meeting. SHAREHOLDERS OF STAAR ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE